Artificial Intelligence Defogging Algorithm for Chest CT Scan Images for Post-Covid-19 Patients Infected with H3N2 Virus

Authors

  • Aravind Jadhav Department of E&CE, Angadi Institute of Technology and Management, Belagavi, Karnataka, India, Affiliated VTU Belagavi, karnataka, India
  • Sanjay Pujari Department of E&CE, KLE College of Engineering & Technology, Chikodi, Belagavi, Karnataka, India

Keywords:

Artificial Intelligence, Human Machine Interface, CNN, deep learning, covid-19, H3N2

Abstract

On the verge of Covid-19 pandemic, new Influenza a H3N2 variant virus is immerging throughout India. It is crucial to identify the impact of post-covid-19 patients and H3N2 infected patients. As all comes to the lung health, the primary element for diagnosis is the CT scan image and MRI of patient regardless of type of the virus. The medicinal strategy is similar due to similar indications of lung infection status in CT images of lungs. The additional and painful symptom of H3N2 infected post-covid-19 patient is the blood in the cough. Doctors need to know the level of infection of lungs in a clear way by defogging the blood clots in the cough present in the lungs or respiratory track. Hence, this paper presents the research to identify with defogging of lung CT image analysis by capturing the more prominent area of lung CT images more clear vision. The proposed research presents the new algorithm named ‘AI-Defogging’ using artificial intelligence to automatically regenerate the augmented pixels out of lung CT images.

Downloads

Download data is not yet available.

References

Fan, Deng-Ping, et al. "Inf-net: Automatic covid-19 lung infection segmentation from ct images." IEEE Transactions on Medical Imaging 39.8 (2020): 2626-2637.

Bolton, Marcus J., et al. "Antigenic and virological properties of an H3N2 variant that continues to dominate the 2021–22 Northern Hemisphere influenza season." Cell Reports 39.9 (2022): 110897.

Dwibedi, B., et al. "Epidemiological and clinical profile of Influenza A (H1N1) pdm09 in Odisha, eastern India." Heliyon 5.10 (2019): e02639.

Matos, Aline da Rocha, et al. "Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities." Emerging microbes & infections 8.1 (2019): 1763-1776.

Cui, X. R., Guo, Y. H., & Liu, Q. Q. (2022). Cangma Huadu granules, a new drug with great potential to treat coronavirus and influenza infections, exert its efficacy through anti-inflammatory and immune regulation. Journal of Ethnopharmacology, 287, 114965.

Wang, N., Li, E., Deng, H., Yue, L., Zhou, L., Su, R., ... & Gao, Y. (2023). Inosine: A broad- spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation. Journal of Pharmaceutical Analysis, 13(1), 11-23.

Lin, H. Y., Zeng, Y. T., Lin, C. J., Harroun, S. G., Anand, A., Chang, L., ... & Huang, C. C. (2022). Partial carbonization of quercetin boosts the antiviral activity against H1N1 influenza A virus. Journal of Colloid and Interface Science, 622, 481-493.

Yu, M., Zhu, Y., Qu, X., Hou, X., Xin, T., & Li, G. (2023). Differences in clinical characteristics and chest CT findings between severe and critical H1N1 pneumonia. The Clinical Respiratory Journal.

Sawant, P., & Sreemathy, R. (2022). A Survey on Image Processing and Machine Learning Techniques for Detection of Pulmonary Diseases Based on CT Images. In Advanced Machine Intelligence and Signal Processing (pp. 707-719). Singapore: Springer Nature Singapore.

Fischer, T., El Baz, Y., Scanferla, G., Graf, N., Waldeck, F., Kleger, G. R., ... & Albrich, W. C. (2022). Comparison of temporal evolution of computed tomography imaging features in COVID-19 and influenza infections in a multicenter cohort study. European Journal of Radiology Open, 9, 100431.

Kumar, S., Nagar, R., Bhatnagar, S., Vaddi, R., Gupta, S. K., Rashid, M., ... & Alkhalifah, T. (2022). Chest X ray and cough sample based deep learning framework for accurate diagnosis of COVID-19. Computers and Electrical Engineering, 103, 108391.

Zhou, L., Meng, X., Huang, Y., Kang, K., Zhou, J., Chu, Y., ... & Gao, X. (2022). An interpretable deep learning workflow for discovering subvisual abnormalities in CT scans of COVID- 19 inpatients and survivors. Nature Machine Intelligence, 4(5), 494-503.

Tabrizchi, H., Razmara, J., Mosavi, A., & Varkonyi-Koczy, A. R. (2022, April). Deep Learning Applications for COVID-19: A Brief Review. In Research and Education: Traditions and Innovations: Proceedings of the 19th International Conference on Global Research and Education (Inter-Academia 2021) (pp. 117-130). Singapore: Springer Singapore.

Gupta, A., Jain, V., & Singh, A. (2022). Stacking ensemble-based intelligent machine learning model for predicting post-COVID-19 complications. New Generation Computing, 40(4), 987-1007.

Roth, H. R., Xu, Z., Tor-Díez, C., Jacob, R. S., Zember, J., Molto, J., ... & Linguraru, M. G. (2022). Rapid artificial intelligence solutions in a pandemic—The COVID-19-20 Lung CT Lesion Segmentation Challenge. Medical image analysis, 82, 102605.

Mei, X.et al.Artificial intelligence–enabled rapid diagnosis of patients with COVID- Nature Medicine, 1-5 (2020).

A Deshpande, VV Estrela, P Patavardhan, “The DCT-CNN-ResNet50 architecture to classify with super-resolution, convolutional neural network, and the ResNet50, Neuroscience Informatics, 2021

Downloads

Published

25.12.2023

How to Cite

Jadhav, A. ., & Pujari, S. . (2023). Artificial Intelligence Defogging Algorithm for Chest CT Scan Images for Post-Covid-19 Patients Infected with H3N2 Virus. International Journal of Intelligent Systems and Applications in Engineering, 12(2), 119–128. Retrieved from https://ijisae.org/index.php/IJISAE/article/view/4227

Issue

Vol. 12 No. 2 (2024)

Section

Research Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJISAE open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.